CERVICAL SCREENING

Cervical Screening London (CSL) is a service provided for the NHS through a partnership between Health Services Laboratories (HSL) and London North West University Healthcare Trust (LNWUH)

Cervical Screening London (CSL) will provide a comprehensive, single-site HPV primary screening service for the NHS Cervical Screening Programme in London.
Based in HSL’s flagship laboratory, the Halo, CSL will draw on HSL’s specialist pathology expertise and LNWUH’s outstanding training and development opportunities to deliver a world-class cervical screening service.

HSL is a clinically-led provider of pathology and diagnostic services to the NHS. A partnership between The Doctors Laboratory, Royal Free London NHS Foundation Trust and University College London Hospitals NHS Foundation Trust, HSL’s purpose is to deliver medically-led diagnostics, innovation, value and long-term investment to the health economy.

LNWUH is home to the London Regional Cytology Training Centre, a fully accredited educational hub which provides high quality, whole pathway cancer screening training for healthcare professionals in London and the South East. 

About HPV primary screening

Human papillomavirus (HPV) primary screening is a new way of examining cervical screening samples, in which HPV testing replaces cytology (examining cells under a microscope) as the first step in the screening process.

High risk sub-types of HPV (hrHPV) cause 99% of all cervical cancers. The transition from cytology to HPV primary screening will help to identify more women at risk of developing cervical cancer and prevent around 600 additional cancers each year. 

HPV primary screening will be rolled out across the NHS Cervical Screening Programme in England by the end of December 2019. 

Information for sample takers 

The rollout of HPV primary screening across England will coincide with the centralisation of cervical screening laboratory services.

From 2 December 2019, all NHS cervical screening samples in London will be transported to CSL’s central London laboratory, the Halo, for testing. HPV testing services will be co-located with cervical cytology to provide a single seamless service. Local colposcopy services will not change.

Cervical samples will continue to be taken in the same way as before. There are new protocols for the follow-up and management of women according to the outcome of their HPV test:

You will receive regular updates from CSL with more information as we get closer to December. These are available to download below.

Update 1 – September 2019
Update 2 – October 2019

     

 

If you have any questions, please get in touch on csl@hslpathology.com

HSL is a partnership between The Doctors Laboratory, Royal Free London NHS Foundation Trust (the Royal Free London) and University College London Hospitals NHS Foundation Trust (UCLH)

Health Services Laboratories
Health Services Laboratories
Health Services Laboratories